Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329523 · ClinicalTrials.gov registry record
A Study to Compare Genetic Variations of IGF-I and IGF-II
A clinical trial, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT01329523: Completed study, sponsored by Avera McKennan Hospital & University Health Center.
NCT01329523 is a clinical trial that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01329523 has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of the AD patients and individuals without AD matched by age to the AD patients.
Primary Outcome
This study consists of a single clinic visit. After subject has completed the informed consent process and meets eligibility criteria, a blood sample and a saliva sample will be collected. Genetic results from this one-time specimen collection will be evaluated and compared with results from participants in the other two study groups. Outcomes will be measured comparatively.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-10 |
What the finished NCT01329523 record still lists
NCT01329523 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01329523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01329523 about?
NCT01329523 is a clinical study titled "A Study to Compare Genetic Variations of IGF-I and IGF-II". The purpose of this study is to determine if insulin-like growth factors (IGF) play a role in the development of dementia, specifically Alzheimer's disease (AD). The study will compare results from genetic testing between patients with AD and two other groups: younger biological family members of th...
What is the current status of trial NCT01329523?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-11. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01329523?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia